Indications & Dose:
Treatment and peri-operative prophylaxis of haemorrhage in patients with congenital deficiency of factors II, VII, IX, or X if purified specific coagulation factors not available | Treatment and peri-operative prophylaxis of haemorrhage in patients with acquired deficiency of factors II, VII, IX, or X (e.g. during warfarin treatment)
% BY INTRAVENOUS INFUSION
% Adult: (consult haematologist)
Major bleeding in patients on warfarin following phytomenadione (initiated under specialist supervision)
% BY INTRAVENOUS INFUSION
% Adult: 25–50 units/kg
Contraindications:
Angina . history of heparin induced thrombocytopenia . recent myocardial infarction (except in life-threatening haemorrhage following overdosage of oral anticoagulants, and before induction of fibrinolytic therapy)
Side Effects:
% Rare Headache . antibody formation .
% Very rare Anaphylaxishypersensitivity reactions . pyrexia
% Frequency not known Disseminatedintravascular coagulation . nephrotic syndrome . thrombotic events
HEPATIC IMPAIRMENT Monitor closely in hepatic impairment (risk of thromboembolic complications).
Cautions:
Disseminated coagulation history of myocardial infarction or coronary heart disease . postoperative use . riskof thrombosis
Precautions:
Interaction:
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team